Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1990
Bioequivalence of two thorazine tablet formulations using radioimmunoassay and gas chromatographic-mass spectrometric methods
K K Midha, G McKay, B S Chakraborty, et al.
Therapeutic Drug Monitoring
|
September 1, 1987
Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites
K K Midha, J W Hubbard, J K Cooper, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Interconversion between haloperidol and reduced haloperidol in healthy volunteers
B S Chakraborty, J W Hubbard, E M Hawes, et al.
Drug Metabolism and Drug Interactions
|
January 1, 1988
S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers
B S Chakraborty, E M Hawes, G McKay, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1989
Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol
K K Midha, B S Chakraborty, D A Ganes, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1989
Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study
B S Chakraborty, K K Midha, G McKay, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1993
Synthesis of the N-oxides of phenothiazine antipsychotic agents
T J Jaworski, M S Sardessai, M Aravagiri, et al.
Therapeutic Drug Monitoring
|
June 1, 1993
Clinical perspectives of some neuroleptics through development and application of their assays
K K Midha, S R Marder, T J Jaworski, et al.
Therapeutic Drug Monitoring
|
January 1, 1985
Therapeutic monitoring of chlorpromazine I: Pitfalls in plasma analysis
J W Hubbard, J K Cooper, E M Hawes, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1990
Bioequivalence of two thorazine tablet formulations using radioimmunoassay and gas chromatographic-mass spectrometric methods
K K Midha, G McKay, B S Chakraborty, et al.
Therapeutic Drug Monitoring
|
September 1, 1987
Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites
K K Midha, J W Hubbard, J K Cooper, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Interconversion between haloperidol and reduced haloperidol in healthy volunteers
B S Chakraborty, J W Hubbard, E M Hawes, et al.
Drug Metabolism and Drug Interactions
|
January 1, 1988
S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers
B S Chakraborty, E M Hawes, G McKay, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1989
Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol
K K Midha, B S Chakraborty, D A Ganes, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1989
Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study
B S Chakraborty, K K Midha, G McKay, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1993
Synthesis of the N-oxides of phenothiazine antipsychotic agents
T J Jaworski, M S Sardessai, M Aravagiri, et al.
Therapeutic Drug Monitoring
|
June 1, 1993
Clinical perspectives of some neuroleptics through development and application of their assays
K K Midha, S R Marder, T J Jaworski, et al.
Therapeutic Drug Monitoring
|
January 1, 1985
Therapeutic monitoring of chlorpromazine I: Pitfalls in plasma analysis
J W Hubbard, J K Cooper, E M Hawes, et al.
Page
of 11